Peroxisome proliferator activated receptor gamma (PPARγ) agonist rosiglitizone inhibits upregulation of mucin gene expression in two airway epithelial cell lines Source: Eur Respir J 2005; 26: Suppl. 49, 97s Year: 2005
Role of NF-?B and PPAR-? in lung inflammation induced by monocyte-derived microparticles Source: Eur Respir J 2011; 37: 1494-1502 Year: 2011
Peroxisome proliferator-activated receptor gamma antagonist, GW9662, inhibits microparticles generation by calcium ionophore-stimulated monocytes/macrophages Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Activation of airway epithelial cell inhibited by peroxisome proliferator-activated receptor γ Source: Eur Respir J 2006; 28: Suppl. 50, 229s Year: 2006
PPAR-γ agonists as therapy for diseases involving airway neutrophilia Source: Eur Respir J 2004; 24: 18-23 Year: 2004
Interferon gamma decreases interleukin-8 production and neurokinin-1 receptor expression in lung alveolar epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 80s Year: 2001
Liver-X-receptor agonists, but not dexamethasone, inhibit leukotriene production from human white blood cells pretreated with GM-CSF and activated with fMLP Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007
dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells Source: Eur Respir J 2005; 26: 795-803 Year: 2005
Toll-like receptor 3-mediated synthesis of eotaxin-1 from human bronchial smooth muscle cells stimulated with double-stranded RNA Source: Eur Respir J 2006; 28: Suppl. 50, 227s Year: 2006
The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells Source: Eur Respir J 2006; 28: Suppl. 50, 339s Year: 2006
Regulation of eotaxin gene transcription by peroxisome proliferator-activated receptor γ agonists in human airway smooth muscle cells: interactions with glucocorticoids and β2 -agonists Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005
The muscarinic receptors promote IL-8 release in airway epithelial cells via the pERK42/44 and NF-kB pathways Source: Eur Respir J 2006; 28: Suppl. 50, 746s Year: 2006
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
The GLP-1 receptor agonist Liraglutide attenuates intermittent hypoxia-induced pro-inflammatory macrophage polarization in primary macrophages Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing Year: 2021
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
PPAR ligands decrease human airway smooth muscle cell migration and extracellular matrix synthesis Source: Eur Respir J 2013; 41: 425-432 Year: 2013
RANTES expression induced by Toll-like receptor 3 and 4 ligands on rat airway smooth muscle cells Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009
A long-acting β2-adrenergic receptor agonist increases cAMP-induced chloride secretion in human airway epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 555s Year: 2004
Histamine modulates interleukin 10 secretion from human alveolar macrophages via H2 and H4 histamine receptors Source: Eur Respir J 2007; 30: Suppl. 51, 690s Year: 2007
Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005